| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |